← Back to Search

Cystomanometer Device for Neurogenic Bladder

N/A
Recruiting
Led By Christopher S Cooper, MD
Research Sponsored by Christopher Cooper
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have diagnosed neurogenic bladder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two weeks
Awards & highlights

Study Summary

This trial will test a new device that monitors pressure for people with neurogenic bladders who use clean intermittent catheterization. The device is already accurate compared to the gold standard.

Who is the study for?
This trial is for individuals with a neurogenic bladder, which means their bladder muscles don't work properly due to nerve damage. Participants must be using urinary catheters regularly. There are no specific exclusion criteria mentioned, so it seems open to anyone who fits the inclusion condition.Check my eligibility
What is being tested?
The study is testing a new device called Cystomanometer that measures bladder pressure and can be attached to standard urinary catheters. The focus of this trial is on how patients and caregivers manage with the device when used at home.See study design
What are the potential side effects?
Since this trial involves a non-invasive monitoring device rather than medication or surgery, there may not be direct side effects from its use. However, discomfort or inconvenience while handling the device could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a neurogenic bladder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Home use of bladder pressure monitoring device

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neurogenic Bladder PatientExperimental Treatment1 Intervention
Patients with neurogenic bladder

Find a Location

Who is running the clinical trial?

Christopher CooperLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled
Christopher S Cooper, MDPrincipal InvestigatorUniversity of Iowa
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Urodynamics Testing Clinical Trial Eligibility Overview. Trial Name: NCT04128709 — N/A
Neurogenic Bladder Research Study Groups: Neurogenic Bladder Patient
Neurogenic Bladder Clinical Trial 2023: Urodynamics Testing Highlights & Side Effects. Trial Name: NCT04128709 — N/A
Urodynamics Testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04128709 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the highest possible number of individuals engaging in this clinical experiment?

"Affirmative. Clinicaltrials.gov reports that, since its initial posting on November 19th 2019 and last edit on May 17th 2022, this medical trial is still open for recruitment. Presently the research team needs 50 participants from a single site to complete their study."

Answered by AI

To whom is this clinical trial open for participation?

"The study is currently recruiting 50 individuals with neurogenic bladder aged 1-99. To qualify, applicants must have a confirmed diagnosis of neurogenic bladder."

Answered by AI

Does this research include participants who are of age 20 and above?

"This research seeks participants who are between 1 and 99 years of age."

Answered by AI

Are individuals currently being admitted to this experimental endeavor?

"According to the data available on clinicaltrials.gov, this clinical trial is still open for registration and enrolling participants. It was first listed in November 2019 and its most recent update occurred back in May 2022."

Answered by AI
~5 spots leftby Dec 2024